LNGR


Longevity Thematic ETF

Fund Summary

The Global X Longevity Thematic ETF (LNGR) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.

Fund Objective

The Global X Longevity Thematic ETF (LNGR) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Global Longevity Thematic Index.

Why LNGR?

High Growth Potential

LNGR enables investors to access high growth potential through companies at the leading edge of a long-term, structural demographic trend affecting multiple sectors of the global economy.

Unconstrained Approach

LNGR's composition transcends classic sector, industry, and geographic classifications by tracking an emerging theme.

ETF Efficiency

In a single trade, LNGR delivers access to dozens of companies with high exposure to the Longevity theme.

Fund Details As of 6/3/20

Key Facts

Ticker LNGR
Inception Date 5/9/16
CUSIP 37954Y772
ISIN US37954Y7720
Bloomberg Index Ticker ILNGRNT
Primary Exchange Nasdaq

Stats & Fees

Net Assets $26,940,268
NAV $24.49
Shares Outstanding 1,100,000
Total Expense Ratio 0.50%

Distributions

30-Day SEC Yield 0.62%
Distribution Frequency Semi-Annually

Fund Prices As of 6/3/20

NAV Price
Net Asset Value $24.49 Closing Price $24.57
Daily Change $0.11 0.46% Daily Change $0.12 0.47%

Performance History

Cumulative %

Data as of month end (5/31/20)

Fund NAV Closing Price Index
1 Month 7.32% 7.59% 7.34%
3 Months 8.23% 7.21% 8.27%
6 Months 3.39% 2.73% 3.45%
Since Inception 64.34% 68.02% 66.24%

Avg Annualized %

Data as of month end (5/31/20)

Fund NAV Closing Price Index
1 Year 21.32% 20.50% 21.54%
3 Years 11.77% 11.50% 12.00%
Since Inception 13.02% 13.64% 13.33%

Avg Annualized %

Data as of quarter end (3/31/20)

Fund NAV Closing Price Index
1 Year -4.78% -5.32% -4.66%
3 Years 7.33% 7.08% 7.56%
Since Inception 8.52% 9.08% 8.81%

Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized Return is the average return gained or lost by an investment each year over a given time period.

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted.

Fund Characteristics As of 6/3/20

Return on Equity 10.70%
Weighted Avg. Market Cap 43,132 M
2019 2020
Price-to-earnings 30.81 34.39
Price-to-book value 3.78 3.55

Source: AltaVista Research, LLC

Fund Risk Stats As of 6/3/20

Versus Beta
S&P 500 0.89
MSCI EAFE 0.86
MSCI Emg. Mkts 0.66
Standard Deviation 17.70%

Source: AltaVista Research, LLC

Top 10 Holdings

As of 6/3/20
Net Assets (%) Ticker Name SEDOL Market Price ($) Shares Held Market Value ($)
3.08 4519 JP CHUGAI PHARMA CO 6196408 148.22 5,594 829,140.55
3.08 REGN REGENERON PHARMACEUTICALS 2730190 604.28 1,371 828,467.88
3.01 ABBV ABBVIE INC B92SR70 90.89 8,930 811,647.70
2.96 SYK STRYKER CORP 2853688 200.70 3,976 797,983.20
2.89 VRTX VERTEX PHARM 2931034 277.01 2,810 778,398.10
2.85 NOVOB DC NOVO NORDISK A/S-B BHC8X90 64.76 11,855 767,693.25
2.82 EW EDWARDS LIFESCIENCES CORP 2567116 74.73 10,164 759,555.72
2.81 BSX BOSTON SCIENTIFIC CORP 2113434 37.91 19,969 757,024.79
2.72 DXCM DEXCOM INC B0796X4 365.86 2,002 732,451.72
2.69 BMY BRISTOL-MYERS SQUIBB CO 2126335 60.21 12,043 725,109.03
Holdings are subject to change.

Investing involves risk, including the possible loss of principal. The investable universe of companies in which LNGR may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. LNGR is non-diversified.

Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Global X NAVs are calculated using prices as of 4:00 PM Eastern Time. The closing price is the Mid-Point between the Bid and Ask price as of the close of exchange. Closing price returns do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.

Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.

Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.